Copyright Reports & Markets. All rights reserved.

Global Combined Polio Vaccine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Combined Polio Vaccine Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 1 Dose
    • 1.3.3 3 Doses
    • 1.3.4 4 Doses
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Combined Polio Vaccine Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Others
  • 1.5 Global Combined Polio Vaccine Market Size & Forecast
    • 1.5.1 Global Combined Polio Vaccine Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Combined Polio Vaccine Sales Quantity (2021-2032)
    • 1.5.3 Global Combined Polio Vaccine Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Mitsubishi Chemical Group Corp.
    • 2.1.1 Mitsubishi Chemical Group Corp. Details
    • 2.1.2 Mitsubishi Chemical Group Corp. Major Business
    • 2.1.3 Mitsubishi Chemical Group Corp. Combined Polio Vaccine Product and Services
    • 2.1.4 Mitsubishi Chemical Group Corp. Combined Polio Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Mitsubishi Chemical Group Corp. Recent Developments/Updates
  • 2.2 Meiji Holdings Co., Ltd.
    • 2.2.1 Meiji Holdings Co., Ltd. Details
    • 2.2.2 Meiji Holdings Co., Ltd. Major Business
    • 2.2.3 Meiji Holdings Co., Ltd. Combined Polio Vaccine Product and Services
    • 2.2.4 Meiji Holdings Co., Ltd. Combined Polio Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Meiji Holdings Co., Ltd. Recent Developments/Updates
  • 2.3 Panacea Biotec Ltd.
    • 2.3.1 Panacea Biotec Ltd. Details
    • 2.3.2 Panacea Biotec Ltd. Major Business
    • 2.3.3 Panacea Biotec Ltd. Combined Polio Vaccine Product and Services
    • 2.3.4 Panacea Biotec Ltd. Combined Polio Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Panacea Biotec Ltd. Recent Developments/Updates
  • 2.4 Boryung Corp.
    • 2.4.1 Boryung Corp. Details
    • 2.4.2 Boryung Corp. Major Business
    • 2.4.3 Boryung Corp. Combined Polio Vaccine Product and Services
    • 2.4.4 Boryung Corp. Combined Polio Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Boryung Corp. Recent Developments/Updates
  • 2.5 Merck & Co., Inc.
    • 2.5.1 Merck & Co., Inc. Details
    • 2.5.2 Merck & Co., Inc. Major Business
    • 2.5.3 Merck & Co., Inc. Combined Polio Vaccine Product and Services
    • 2.5.4 Merck & Co., Inc. Combined Polio Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Merck & Co., Inc. Recent Developments/Updates
  • 2.6 Sanofi
    • 2.6.1 Sanofi Details
    • 2.6.2 Sanofi Major Business
    • 2.6.3 Sanofi Combined Polio Vaccine Product and Services
    • 2.6.4 Sanofi Combined Polio Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Sanofi Recent Developments/Updates

3 Competitive Environment: Combined Polio Vaccine by Manufacturer

  • 3.1 Global Combined Polio Vaccine Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Combined Polio Vaccine Revenue by Manufacturer (2021-2026)
  • 3.3 Global Combined Polio Vaccine Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Combined Polio Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Combined Polio Vaccine Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Combined Polio Vaccine Manufacturer Market Share in 2025
  • 3.5 Combined Polio Vaccine Market: Overall Company Footprint Analysis
    • 3.5.1 Combined Polio Vaccine Market: Region Footprint
    • 3.5.2 Combined Polio Vaccine Market: Company Product Type Footprint
    • 3.5.3 Combined Polio Vaccine Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Combined Polio Vaccine Market Size by Region
    • 4.1.1 Global Combined Polio Vaccine Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Combined Polio Vaccine Consumption Value by Region (2021-2032)
    • 4.1.3 Global Combined Polio Vaccine Average Price by Region (2021-2032)
  • 4.2 North America Combined Polio Vaccine Consumption Value (2021-2032)
  • 4.3 Europe Combined Polio Vaccine Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Combined Polio Vaccine Consumption Value (2021-2032)
  • 4.5 South America Combined Polio Vaccine Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Combined Polio Vaccine Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Combined Polio Vaccine Sales Quantity by Type (2021-2032)
  • 5.2 Global Combined Polio Vaccine Consumption Value by Type (2021-2032)
  • 5.3 Global Combined Polio Vaccine Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Combined Polio Vaccine Sales Quantity by Application (2021-2032)
  • 6.2 Global Combined Polio Vaccine Consumption Value by Application (2021-2032)
  • 6.3 Global Combined Polio Vaccine Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Combined Polio Vaccine Sales Quantity by Type (2021-2032)
  • 7.2 North America Combined Polio Vaccine Sales Quantity by Application (2021-2032)
  • 7.3 North America Combined Polio Vaccine Market Size by Country
    • 7.3.1 North America Combined Polio Vaccine Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Combined Polio Vaccine Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Combined Polio Vaccine Sales Quantity by Type (2021-2032)
  • 8.2 Europe Combined Polio Vaccine Sales Quantity by Application (2021-2032)
  • 8.3 Europe Combined Polio Vaccine Market Size by Country
    • 8.3.1 Europe Combined Polio Vaccine Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Combined Polio Vaccine Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Combined Polio Vaccine Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Combined Polio Vaccine Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Combined Polio Vaccine Market Size by Region
    • 9.3.1 Asia-Pacific Combined Polio Vaccine Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Combined Polio Vaccine Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Combined Polio Vaccine Sales Quantity by Type (2021-2032)
  • 10.2 South America Combined Polio Vaccine Sales Quantity by Application (2021-2032)
  • 10.3 South America Combined Polio Vaccine Market Size by Country
    • 10.3.1 South America Combined Polio Vaccine Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Combined Polio Vaccine Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Combined Polio Vaccine Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Combined Polio Vaccine Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Combined Polio Vaccine Market Size by Country
    • 11.3.1 Middle East & Africa Combined Polio Vaccine Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Combined Polio Vaccine Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Combined Polio Vaccine Market Drivers
  • 12.2 Combined Polio Vaccine Market Restraints
  • 12.3 Combined Polio Vaccine Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Combined Polio Vaccine and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Combined Polio Vaccine
  • 13.3 Combined Polio Vaccine Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Combined Polio Vaccine Typical Distributors
  • 14.3 Combined Polio Vaccine Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Combined Polio Vaccine market size was valued at US$ 321 million in 2025 and is forecast to a readjusted size of US$ 452 million by 2032 with a CAGR of 5.1% during review period.
    Combined polio vaccine (IPV) is a formulation with multiple vaccine components that protects against poliomyelitis (polio) as well as specific diseases such as pertussis, diphtheria and tetanus. This combined vaccine can activate the immune response to multiple pathogens at the same time, reduce the number of vaccinations, improve the efficiency of vaccination, and provide comprehensive protection for children.
    This report is a detailed and comprehensive analysis for global Combined Polio Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Combined Polio Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Combined Polio Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Combined Polio Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Combined Polio Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Combined Polio Vaccine
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Combined Polio Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Mitsubishi Chemical Group Corp., Meiji Holdings Co., Ltd., Panacea Biotec Ltd., Boryung Corp., Merck & Co., Inc., Sanofi, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Combined Polio Vaccine market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    1 Dose
    3 Doses
    4 Doses
    Market segment by Application
    Hospital
    Clinic
    Others
    Major players covered
    Mitsubishi Chemical Group Corp.
    Meiji Holdings Co., Ltd.
    Panacea Biotec Ltd.
    Boryung Corp.
    Merck & Co., Inc.
    Sanofi
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Combined Polio Vaccine product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Combined Polio Vaccine, with price, sales quantity, revenue, and global market share of Combined Polio Vaccine from 2021 to 2026.
    Chapter 3, the Combined Polio Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Combined Polio Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Combined Polio Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Combined Polio Vaccine.
    Chapter 14 and 15, to describe Combined Polio Vaccine sales channel, distributors, customers, research findings and conclusion.

    Buy now